How Untreated Varicose Veins Can Lead to Leg Ulcers, Clots, and Skin Damage]

Understanding Varicose Veins Varicose veins arise from a chronic circulatory disorder called chronic venous insufficiency ...

Permanence Vs. Maintenance: Rethinking The Future Of Aesthetic Medicine

A permanence-first strategy aligns with modern health trends: addressing root causes, building tissue resilience and reducing long-term dependency.
Sportschosun on MSN

Hemp Extracting Ingredients Lower Acne and Sebum Production...Involved in skin composition protein c...

A team led by Professor Seo Dae-heon of the Department of Dermatology at Seoul National University Hospital (researcher Yoon ...

Dr. Cameron Rokhsar Presents First Large Case Series on Non-Surgical Treatment of Lipomas Using Kybella® (Deoxycholic Acid) Injections

New York, NY – December 16, 2025 – In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, ...
CURE

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...
Fierce Pharma

J&J scores FDA nod for subcutaneous lung cancer shot, sharpening its challenge to Tagrisso

J&J has hypothesized that subcutaneous absorption of the drug may potentially enhance immune-mediated anticancer activity.
The American Journal of Managed Care

FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC

The FDA has approved the subcutaneous administration of a fixed combination of amivantamab (Rybrevant; Johnson & Johnson) and a recombinant human hyaluronidase for patients with non–small cell lung ...
News-Medical.Net on MSN

mRNA therapy rejuvenates immune function in aging mice

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...